Corrigendum to "Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data" Gynecol. Oncol. 154 (2019) 441-448.
| Authors | Paul A Cohen, Aime Powell, Steffen Böhm, C Blake Gilks, Colin J R Stewart, Tarek M Meniawy, Max Bulsara, Stefanie Avril, Eleanor C Brockbank, Tjalling Bosse, Gustavo Rubino de Azevedo Focchi, Raji Ganesan, Rosalind M Glasspool, Brooke E Howitt, Hyun-Soo Kim, Jung-Yun Lee, Nhu D Le, Michelle Lockley, Ranjit Manchanda, Trupti Mandalia, W Glenn McCluggage, Iain McNeish, Divya Midha, Radhika Srinivasan, Yun Yi Tan, Rachael van der Griend, Mayu Yunokawa, Gian F Zannoni, HGSC CRS Collaborative Network (Supplementary 1), Naveena Singh |
| Journal | Gynecologic oncology
(Gynecol Oncol)
Vol. 161
Issue 1
Pg. 328-329
(Apr 2021)
ISSN: 1095-6859 [Electronic] United States |
| PMID | 33551198
(Publication Type: Published Erratum)
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|
